By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous antidepressants > Vilazodone > Vilazodone Dosage
Miscellaneous antidepressants
https://themeditary.com/dosage-information/vilazodone-dosage-7188.html

Vilazodone Dosage

Drug Detail:Vilazodone (Vilazodone [ vil-az-oh-done ])

Drug Class: Miscellaneous antidepressants

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Depression

Initial dose: 10 mg orally once a day for 7 days, followed by 20 mg orally once a day for an additional 7 days
Maintenance dose: 40 mg orally once a day

Comment: This drug should be taken with food.

Use: Treatment of major depressive disorder (MDD)

Renal Dose Adjustments

No adjustment recommended

Liver Dose Adjustments

No adjustment recommended

Dose Adjustments

Switching to/from MAOI Antidepressants:

  • At least 14 days must elapse between the discontinuation of the MAOI and initiation of this drug OR after stopping this drug and starting an MAOI antidepressant.

Concomitant Strong CYP450 3A4 Inhibitors (e.g., itraconazole, clarithromycin, voriconazole):
  • The daily dose should not exceed 20 mg.
  • The recommended dose may be resumed when the inhibitor is discontinued.

Concomitant Strong CYP450 3A4 Inducers (e.g., carbamazepine, phenytoin, rifampin):
  • Healthcare providers should consider increasing the dose (up to 80 mg once a day) over 1 to 2 weeks in patients taking strong CYP450 3A4 inducers for longer than 14 days.
  • The recommended dose may be resumed over 1 to 2 weeks when the inducer is discontinued.

Missed Dose:
  • Patients should take the dose as soon as remembered UNLESS it is almost time for the next dose. If it is time for the next dose, the patient should skip the missed dose and take the next dose at the regular time.
  • Patients should avoid taking 2 doses at the same time.

Discontinuing Treatment:
  • Patients receiving the 40 mg/day dose: Taper to 20 mg orally for 4 days, then 10 mg daily once a day for 3 days before discontinuing treatment.
  • Patients receiving the 20 mg/day dose: Taper to 10 mg orally for 7 days before discontinuing treatment.

Precautions

US BOXED WARNINGS:
SUICIDAL THOUGHTS AND BEHAVIORS:

  • Antidepressants increased the risk of suicidal thoughts and behaviors in patients aged 24 years and younger in short-term studies.
  • Monitor closely for clinical worsening and for emergence of suicidal thoughts and behaviors.
  • The safety and efficacy of this drug have not been established in pediatric patients.

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Patients should be reassessed periodically to determine the need for maintenance treatment and the appropriate dose for treatment.

Patient advice:
  • Patients and their caregivers should be advised about the benefits and risks associated with treatment with vilazodone and should be counseled in its appropriate use.
  • Patients should avoid alcohol while taking this drug.
  • Patients should be advised to notify their healthcare provider if they develop an allergic reaction such as rash, hives, swelling, or difficulty breathing.
  • Patients should use caution about operating hazardous machinery, including automobiles, until they are reasonably certain that vilazodone does not adversely affect their ability to engage in such activities.

Frequently asked questions

  • What are some common side effects of antidepressants?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by